Trial intelligence / Profile preview

Propranolol-assisted memory reconsolidation for nicotine addiction

NL-OMON48641Active, not recruiting

Sponsor
TNO
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of propranolol in nicotine dependence, sponsored by TNO. Primary endpoint: Smoking status. Started Jan 2020; status: active, not recruiting.

02

Drugs

propranolol
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NL-OMON48641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON48641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call